JP2013507361A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013507361A5 JP2013507361A5 JP2012533139A JP2012533139A JP2013507361A5 JP 2013507361 A5 JP2013507361 A5 JP 2013507361A5 JP 2012533139 A JP2012533139 A JP 2012533139A JP 2012533139 A JP2012533139 A JP 2012533139A JP 2013507361 A5 JP2013507361 A5 JP 2013507361A5
- Authority
- JP
- Japan
- Prior art keywords
- isoflavone
- animal
- administered
- amount
- package
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 claims 20
- 235000008696 isoflavones Nutrition 0.000 claims 20
- 238000000034 method Methods 0.000 claims 19
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 claims 17
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N daidzein Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 claims 6
- HKQYGTCOTHHOMP-UHFFFAOYSA-N formononetin Chemical compound C1=CC(OC)=CC=C1C1=COC2=CC(O)=CC=C2C1=O HKQYGTCOTHHOMP-UHFFFAOYSA-N 0.000 claims 4
- 229930182478 glucoside Natural products 0.000 claims 4
- OZBAVEKZGSOMOJ-MIUGBVLSSA-N glycitin Chemical compound COC1=CC(C(C(C=2C=CC(O)=CC=2)=CO2)=O)=C2C=C1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O OZBAVEKZGSOMOJ-MIUGBVLSSA-N 0.000 claims 4
- 150000002515 isoflavone derivatives Chemical class 0.000 claims 3
- 201000000585 muscular atrophy Diseases 0.000 claims 3
- 208000001076 sarcopenia Diseases 0.000 claims 3
- GMTUGPYJRUMVTC-UHFFFAOYSA-N Daidzin Natural products OC(COc1ccc2C(=O)C(=COc2c1)c3ccc(O)cc3)C(O)C(O)C(O)C=O GMTUGPYJRUMVTC-UHFFFAOYSA-N 0.000 claims 2
- KYQZWONCHDNPDP-UHFFFAOYSA-N Daidzoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-UHFFFAOYSA-N 0.000 claims 2
- XJTZHGNBKZYODI-UHFFFAOYSA-N Glycitin Natural products OCC1OC(Oc2ccc3OC=C(C(=O)c3c2CO)c4ccc(O)cc4)C(O)C(O)C1O XJTZHGNBKZYODI-UHFFFAOYSA-N 0.000 claims 2
- 230000032683 aging Effects 0.000 claims 2
- 235000007240 daidzein Nutrition 0.000 claims 2
- KYQZWONCHDNPDP-QNDFHXLGSA-N daidzein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-QNDFHXLGSA-N 0.000 claims 2
- 235000015872 dietary supplement Nutrition 0.000 claims 2
- 235000019126 equol Nutrition 0.000 claims 2
- ADFCQWZHKCXPAJ-GFCCVEGCSA-N equol Chemical compound C1=CC(O)=CC=C1[C@@H]1CC2=CC=C(O)C=C2OC1 ADFCQWZHKCXPAJ-GFCCVEGCSA-N 0.000 claims 2
- RIKPNWPEMPODJD-UHFFFAOYSA-N formononetin Natural products C1=CC(OC)=CC=C1C1=COC2=CC=CC=C2C1=O RIKPNWPEMPODJD-UHFFFAOYSA-N 0.000 claims 2
- TZBJGXHYKVUXJN-UHFFFAOYSA-N genistein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O TZBJGXHYKVUXJN-UHFFFAOYSA-N 0.000 claims 2
- 235000006539 genistein Nutrition 0.000 claims 2
- 229940045109 genistein Drugs 0.000 claims 2
- ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 claims 2
- 150000008131 glucosides Chemical class 0.000 claims 2
- NNUVCMKMNCKPKN-UHFFFAOYSA-N glycitein Natural products COc1c(O)ccc2OC=C(C(=O)c12)c3ccc(O)cc3 NNUVCMKMNCKPKN-UHFFFAOYSA-N 0.000 claims 2
- 235000008466 glycitein Nutrition 0.000 claims 2
- DXYUAIFZCFRPTH-UHFFFAOYSA-N glycitein Chemical compound C1=C(O)C(OC)=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 DXYUAIFZCFRPTH-UHFFFAOYSA-N 0.000 claims 2
- ADFCQWZHKCXPAJ-UHFFFAOYSA-N indofine Natural products C1=CC(O)=CC=C1C1CC2=CC=C(O)C=C2OC1 ADFCQWZHKCXPAJ-UHFFFAOYSA-N 0.000 claims 2
- -1 malonyl glucosides Chemical class 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 206010028289 Muscle atrophy Diseases 0.000 claims 1
- 230000037208 balanced nutrition Effects 0.000 claims 1
- 235000019046 balanced nutrition Nutrition 0.000 claims 1
- 230000009286 beneficial effect Effects 0.000 claims 1
- 230000020763 muscle atrophy Effects 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27863309P | 2009-10-09 | 2009-10-09 | |
| US61/278,633 | 2009-10-09 | ||
| PCT/US2010/002722 WO2011043827A1 (en) | 2009-10-09 | 2010-10-08 | Methods for preventing or treating sarcopenia and muscle atrophy in animals |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013507361A JP2013507361A (ja) | 2013-03-04 |
| JP2013507361A5 true JP2013507361A5 (enExample) | 2013-11-21 |
| JP6122638B2 JP6122638B2 (ja) | 2017-04-26 |
Family
ID=43857050
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012533139A Active JP6122638B2 (ja) | 2009-10-09 | 2010-10-08 | 動物のサルコペニア及び筋萎縮症を予防又は治療する方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US9301941B2 (enExample) |
| EP (1) | EP2485740B1 (enExample) |
| JP (1) | JP6122638B2 (enExample) |
| CN (1) | CN102573857A (enExample) |
| AU (1) | AU2010303872B2 (enExample) |
| BR (1) | BR112012008238A2 (enExample) |
| CA (1) | CA2776950C (enExample) |
| ES (1) | ES2688447T3 (enExample) |
| IN (1) | IN2012DN02624A (enExample) |
| MX (1) | MX2012004118A (enExample) |
| RU (1) | RU2558534C2 (enExample) |
| WO (1) | WO2011043827A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012170546A1 (en) * | 2011-06-06 | 2012-12-13 | University Of Iowa Research Foundation | Methods of inhibiting muscle atrophy |
| US11090313B2 (en) | 2010-05-20 | 2021-08-17 | University Of Iowa Research Foundation | Methods for inhibiting muscle atrophy |
| CN105708834A (zh) * | 2011-10-18 | 2016-06-29 | 株式会社爱茉莉太平洋 | 包含丁香脂素的sirt1活化剂 |
| WO2015166887A1 (ja) * | 2014-04-28 | 2015-11-05 | サントリーホールディングス株式会社 | ケルセチン配糖体を含有する筋萎縮抑制剤 |
| CN120436205A (zh) | 2015-02-13 | 2025-08-08 | 马斯公司 | 包装宠物食物产品 |
| KR20170002846A (ko) | 2015-06-30 | 2017-01-09 | (주)아모레퍼시픽 | 콩잎 추출물을 유효성분으로 함유하는 근질환 억제 및 예방용 조성물 |
| GB201522304D0 (en) * | 2015-12-17 | 2016-02-03 | Mars Inc | Food product for reducing muscle breakdown |
| GB201721627D0 (en) | 2017-12-21 | 2018-02-07 | Mars Inc | Pet food product |
| CN108635571B (zh) * | 2018-07-19 | 2021-10-22 | 西安交通大学医学院第一附属医院 | 鸢尾素(irisin)在制备预防及治疗重症急性胰腺炎药物中的应用 |
| CN114502157A (zh) * | 2019-10-04 | 2022-05-13 | 三得利控股株式会社 | 抑制肌肉量的降低、预防其降低、维持、恢复或增加肌肉量用组合物 |
| KR102623198B1 (ko) * | 2020-02-26 | 2024-01-10 | 한국 한의학 연구원 | 돌콩 추출물을 유효성분으로 함유하는 근력강화, 근육증강, 근육분화, 근육재생 또는 근감소의 예방, 개선 또는 치료용 조성물 |
| RU2756154C1 (ru) * | 2020-11-13 | 2021-09-28 | Митхат Зульфугар-Оглы Гасанов | Способ диагностики саркопении у пациентов с хронической болезнью почек 5д стадии, получающих лечение программным гемодиализом |
| KR102803173B1 (ko) * | 2021-02-22 | 2025-05-07 | 한국 한의학 연구원 | 황기 추출물로부터 분리한 화합물을 유효성분으로 함유하는 근력강화, 근육증강, 근육분화, 근육재생, 근감소 또는 근피로의 예방, 개선 또는 치료용 조성물 |
| WO2023140407A1 (ko) * | 2022-01-21 | 2023-07-27 | 경상국립대학교병원 | 쿠메스트롤을 포함하는 근감소증 예방 또는 치료용 약학 조성물 |
| KR102803976B1 (ko) * | 2022-04-06 | 2025-05-07 | 국립강릉원주대학교산학협력단 | 때죽나무 잎 추출물을 포함하는 근력강화용 조성물 |
| WO2025121473A1 (ko) * | 2023-12-06 | 2025-06-12 | 경상국립대학교병원 | 아세틸제니스틴을 포함하는 근감소증의 예방 또는 개선용 약학 조성물 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU166380B (enExample) * | 1973-07-09 | 1975-03-28 | ||
| US6887499B2 (en) * | 2000-05-22 | 2005-05-03 | Enitan A. Bababunmi | Formulation and method for treating skeletal muscle degeneration caused by malnutrition and disease |
| IL145540A0 (en) * | 2000-09-28 | 2002-06-30 | Pfizer Prod Inc | Use of growth hormone secretagogues in conjunction with physical exercise |
| AUPR846401A0 (en) * | 2001-10-25 | 2001-11-15 | Novogen Research Pty Ltd | 6-Hydroxy isoflavones, derivatives and medicaments involving same |
| JP5384777B2 (ja) * | 2001-12-18 | 2014-01-08 | 有限会社大長企画 | 強筋肉剤、抗炎症剤 |
| US20070185012A1 (en) * | 2003-07-10 | 2007-08-09 | Rajadhyaksha V J | Glycopeptides for the treatment of als and other metabolic and autoimmune disorders |
| AU2005208934A1 (en) * | 2004-01-29 | 2005-08-11 | Elixir Pharmaceuticals, Inc | Treating a viral disorder |
| BRPI0508936A (pt) * | 2004-03-17 | 2007-09-25 | Nestec Sa | composições e métodos para redução ou prevenção de obesidade |
| JP2009537582A (ja) * | 2006-05-24 | 2009-10-29 | ディーエスエム アイピー アセッツ ビー．ブイ． | 有機化合物の新しい用途 |
| PT2054049E (pt) * | 2006-08-24 | 2016-06-02 | Univ Tennessee Res Found | Acilanilidas substituídas e métodos de utilização das mesmas |
-
2010
- 2010-10-08 CA CA2776950A patent/CA2776950C/en active Active
- 2010-10-08 US US13/499,118 patent/US9301941B2/en active Active
- 2010-10-08 IN IN2624DEN2012 patent/IN2012DN02624A/en unknown
- 2010-10-08 WO PCT/US2010/002722 patent/WO2011043827A1/en not_active Ceased
- 2010-10-08 CN CN2010800446421A patent/CN102573857A/zh active Pending
- 2010-10-08 AU AU2010303872A patent/AU2010303872B2/en active Active
- 2010-10-08 MX MX2012004118A patent/MX2012004118A/es active IP Right Grant
- 2010-10-08 RU RU2012118686/13A patent/RU2558534C2/ru not_active IP Right Cessation
- 2010-10-08 BR BR112012008238A patent/BR112012008238A2/pt not_active Application Discontinuation
- 2010-10-08 EP EP10822363.7A patent/EP2485740B1/en active Active
- 2010-10-08 JP JP2012533139A patent/JP6122638B2/ja active Active
- 2010-10-08 ES ES10822363.7T patent/ES2688447T3/es active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013507361A5 (enExample) | ||
| RU2012118686A (ru) | Способы предупреждения или лечения саркопении мышечной атрофии у животных | |
| Oluwole et al. | Role of phenolic acid, tannins, stilbenes, lignans and flavonoids in human health–a review | |
| RU2013150828A (ru) | Способы регулирования экспрессии генов сиртуинов | |
| Salaritabar et al. | Therapeutic potential of flavonoids in inflammatory bowel disease: A comprehensive review | |
| Xiao et al. | Natural flavonoids as promising analgesic candidates: a systematic review | |
| Kumar et al. | Chemistry and biological activities of flavonoids: an overview | |
| Li et al. | A comprehensive review of the metabolism of citrus flavonoids and their binding to bitter taste receptors | |
| TWI747984B (zh) | ＰＧＣ－１α活性化用組成物 | |
| JP2012522030A5 (enExample) | ||
| US20030144219A1 (en) | Formulations and methods for treatment or amelioration of inflammatory conditions | |
| NZ741022A (en) | Flavonoid compositions and methods of use | |
| JP2012522030A (ja) | ヘスペレチンの生体利用率を増大させるためのフラボノイドの使用 | |
| GEP20146104B (en) | Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives | |
| GEP20146145B (en) | Pharmaceutical composition containing glucopyranosyl diphenylmethane derivatives, pharmaceutical dosage form thereof, process of their preparation and usagetherefor improved glycemic control in patient | |
| JP2012511547A (ja) | イソフラボン組成物 | |
| Dwivedi et al. | Molecular structure, biological functions, and metabolic regulation of flavonoids | |
| Jang et al. | Change of isoflavone content during manufacturing of cheonggukjang, a traditional Korean fermented soyfood | |
| Miniello et al. | Soy‐based formulas and phyto‐oestrogens: a safety profile | |
| Atınç et al. | Flavonoidler ve sağlık üzerine etkileri | |
| Ho | Metabolism of flavonoids | |
| Kumar et al. | Potential of flavonoids as anticancer drugs | |
| EA201491050A1 (ru) | Питание, предназначенное для потребления человеком | |
| JP2008542297A5 (enExample) | ||
| He et al. | Phytoestrogens: Pharmacological Potential and Therapeutic Insights for Urinary Tract Infections |